Literature DB >> 7213509

Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694.

H A Davies, J Rhodes, M Thomas.   

Abstract

1 The effect on gastric acid secretion of a mast cell stabiliser FPL-52694 was examined in nine healthy volunteers. 2 The compound which is moderately well absorbed after oral ingestion, was taken for 5 days prior to the measurement of acid secretion and was also given intravenously during part of the gastric test. A submaximal dose of pentagastrin (0.3 microgram/kg/h) was given by intravenous infusion for 2 h in a controlled test and then after administration of FPL-52694. 3 There was a significant reduction (37%) in acid secretion during the second test which was probably due to the effect of the compound on mast cell degranulation in the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213509      PMCID: PMC1401681          DOI: 10.1111/j.1365-2125.1981.tb01101.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma.

Authors:  J B Howell; R E Altounyan
Journal:  Lancet       Date:  1967-09-09       Impact factor: 79.321

2.  Positioning of subject and of nasogastric tube during a gastric secretion study.

Authors:  M A Hassan; M Hobsley
Journal:  Br Med J       Date:  1970-02-21

3.  Treatment of seasonal allergic rhinitis with 2 percent sodium cromoglycate (BP) solution.

Authors:  H Blair; R L Herbert
Journal:  Clin Allergy       Date:  1973-09

4.  Disodium cromoglycate: a novel gastric antiulcer agent?

Authors:  C W Ogle; H K Lau
Journal:  Eur J Pharmacol       Date:  1979-05-15       Impact factor: 4.432

5.  The interaction of histamine with gastrin and carbamylcholine on oxygen uptake by isolated mammalian parietal cells.

Authors:  A H Soll
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells.

Authors:  A H Soll
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Disodium cromoglycate in the treatment of chronic proctitis.

Authors:  R V Heatley; B J Calcraft; J Rhodes; E Owen; B K Evans
Journal:  Gut       Date:  1975-07       Impact factor: 23.059

8.  Effect of cimetidine on histamine- and pentagastrin-stimulated gastric secretion in healthy subjects.

Authors:  E Aadland; A Berstad
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

9.  The effect of orally administered sodium cromoglycate on symptoms of food allergy.

Authors:  A Dannaeus; T Foucard; S G Johansson
Journal:  Clin Allergy       Date:  1977-03
  9 in total
  8 in total

Review 1.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

2.  Gastric juice electrolyte secretion in conscious dogs with gastric fistulae and its modification by FPL 52694, a mast cell stabilizing agent.

Authors:  S P Canfield; B P Curwain
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

3.  Action of FPL 52694 on gastric acid secretion in the healthy human stomach.

Authors:  H J Reimann; U Schmidt; B Ultsch; T J Sullivan; P Wendt
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

4.  Clinical assessment of antisecretory drugs in man.

Authors:  E J Boyd; K G Wormsley
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

5.  Effects of a mast cell stabiliser (FPL 52694) on human gastric secretion.

Authors:  E J Boyd; J A Wilson; K G Wormsley; M H Richards; M J Langman
Journal:  Agents Actions       Date:  1985-09

6.  Characterization of FPL-52694 [5-(2-hydroxypropoxyl)-8-propyl-4-oxo-4H-benzopyran-2-carboxylic acid Na] on histamine release from rat peritoneal mast cells induced by antigen, compound 48/80 and A 23187.

Authors:  K Takeuchi; H Ohtsuki; S Nakagawa; S Okabe
Journal:  Agents Actions       Date:  1985-10

7.  Effects of FPL-52694, a new mast cell stabilizer, on gastric secretion and various acute gastric lesions in rats.

Authors:  K Takeuchi; Y Ishihara; H Kunimi; S Okabe
Journal:  Agents Actions       Date:  1984-06

8.  Inhibition of gastric acid secretion in the conscious dog by the mast-cell stabilizing agent, FPL 52694.

Authors:  S P Canfield; B P Curwain
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.